Cassette for expressing a toxoplasma gondii P30 protein
US6372443B1 · kind B1 · utility
3Cited by
5References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 13, 1996 |
| Grant date | Apr 16, 2002 |
| Priority date | — |
| Expiry date | Mar 13, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/962
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a reagent for the detection or monitoring of a Toxoplasma gondii infection, which includes as a reactive substance a truncated Toxoplasma gondii P30 protein in which all of the hydrophobic C-terminal region of the native protein starting with the amino acid positioned after the amino acid 299 (SEQ ID NO: 1) has been deleted and all of the region of the native protein having the sequence starting with amino acid 31 and ending with the amino acid 299 (SEQ ID NO: 1) is contained. The present invention further describes methods of screening for anti-Toxoplasma antibodies in a biological sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.